Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

31.55
Delayed Data
As of Dec 02
 +0.31 / +0.99%
Today’s Change
20.39
Today|||52-Week Range
35.06
-4.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash8.9M30.7M21.7M16.6M
 
 
 
 
 
Short Term Investment Cash-1.7M21.8M-9.0M--
 
 
 
 
Cash & Short Term Investments101.5M90.8M145.2M210.1M
 
 
 
 
 
 
ReceivablesReceivables1.6M1.7M15.7M12.8M
 
 
 
 
 
 
InventoriesInventories----------
 
Current AssetsOther Current Assets1.6M15.5M9.7M9.2M
 
 
 
 
 
Current Assets104.7M108.0M170.6M232.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.5M5.9M10.2M--
 
 
 
 
Depreciation-4.3M-4.1M-4.3M--
 
 
 
 
Other Assets0.000.000.00----
Total Assets117.0M155.4M246.0M281.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.5M1.9M1.5M3.4M
 
 
 
 
 
Short Term Debt--0.0069.0K--
 
 
Accrued Expenses2.0M1.6M964.0K4.5M
 
 
 
 
 
Other Current Liabilities2.0M1.6M2.3M4.5M
 
 
 
 
 
Other Liabilities4.5M4.7M6.7M7.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.00692.0K159.0K
 
 
 
Deferred Taxes0.00-4.2M-4.6M-8.4M
 
 
 
 
Other Liabilities1.9M1.7M1.9M3.3M
 
 
 
 
 
Total Liabilities6.5M6.6M9.9M11.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock0.00202.0K0.00--
 
 
Common Equity110.5M148.7M236.2M269.9M
 
 
 
 
 
Total Shareholder Equity110.5M148.9M236.2M269.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding17.9M18.6M18.7M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.